In general, several treatment strategies have been employed based on the type of diabetes, for instance, direct administration of insulin for type-1 diabetes and delivery of various therapeutics promoting the insulin release from the β-cells of the pancreas for type-2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.